METASTATIC BREAST CANCER
Clinical trials for METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized chemo tested for tough breast cancers
Disease control TerminatedThis study tested whether a chemotherapy drug called ixabepilone could help control advanced breast cancer that had stopped responding to standard treatments. Researchers used a special test (the DRP) to predict which patients' tumors were most likely to respond. The trial was sm…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough breast cancers that come back fast
Disease control TerminatedThis study tested a drug called Trastuzumab Deruxtecan for people with advanced HER2-positive breast cancer whose cancer returned within a year of finishing prior treatment. The goal was to see if this drug could control the cancer and was safe for patients. The trial was termina…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Trial for tough breast cancer cases halted early
Disease control TerminatedThis study tested an experimental drug called BDC-1001, both alone and combined with an existing drug (pertuzumab), for people with advanced HER2-positive breast cancer that had worsened after standard treatments. The goal was to see if the treatment could shrink tumors and was s…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Targeted therapy tested for Tough-to-Treat breast cancer
Disease control TerminatedThis study tested a drug called futibatinib, alone or with hormone therapy, for people with advanced breast cancer that had spread and had specific genetic changes (FGFR gene amplifications). The goal was to see if the treatment could shrink tumors or control the cancer's growth.…
Matched conditions: METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC